O Klein, J Lynge, L Endahl, B Damholt, L … - Diabetes Obes Metab, 2007 - interscience.wiley.com Methods: Twenty-seven insulin-treated men with type 2 diabetes [body mass index
30.8 ± 2.6 kg/m 2 (mean ± sd), haemoglobin A 1c 7.6 ± 1.1%] were enrolled in
this randomized, double-blind trial and participated in six euglycaemic ... Cited by 71 - Related articles - All 4 versions
A Sola-Gazagnes, C Pecquet, J M'Bemba, E … - The Lancet, 2007 - Elsevier The long-acting insulin analogue detemir differs from native insulin by the
deletion of aminoacid B30 and addition of a myristic acid residue at B29.
Detemir has been available in France since September, 2005. We report four ... Cited by 10 - Related articles - All 10 versions
- ►endojournals.org SE Fineberg, TT Kawabata, D Finco-Kent, RJ … - Endocrine Reviews, 2007 - Endocrine Soc Regardless of purity and origin, therapeutic insulins continue to be immunogenic
in humans. However, severe immunological complications occur rarely, and less
severe events affect a small minority of patients. Insulin autoantibodies ... Cited by 6 - Related articles - BL Direct - All 3 versions
L Heinzerling, K Raile, H Rochlitz, T … - Insulin, 2008 - aid.org.tr 36 yaşındaki tip 1 diabetli kadın hastada ürtiker, kaşıntı, anjioödem,
çift görme, genel yorgunluk, çarpıntı, paresteziler, enjeksiyon bölgesinde
endürasyon, maküler döküntü ile karakterize klinik bulgular ... Cited by 9 - Related articles - Cached - BL Direct - All 4 versions
- ►diabetesjournals.org [PDF] L Stechemesser, M Hofmann, T Hawranek, R … - Diabetes care, 2006 - Am Diabetes Assoc In their letter to the editor, Damon et al. (1) presented their observation of a
local allergic reaction to insulin detemir. According to the patient's clinical
appearance, they classified it as a type III allergy. Another case of a ... Cited by 2 - Related articles - BL Direct - All 5 versions
S Ghosh, V McCann, L Bartle, A Collier, I … - Diabetic medicine: a journal of the British Diabetic …, 2007 - ncbi.nlm.nih.gov 1: Diabet Med. 2007 Nov;24(11):1307. Allergy to insulin detemir. Ghosh S,
McCann V, Bartle L, Collier A, Malik I. Publication Types ... Cited by 2 - Related articles - BL Direct - All 4 versions
JC Philips, A Scheen - Vascular Health and Risk Management, 2006 - pubmedcentral.nih.gov Insulin detemir is a soluble long-acting human insulin analogue at neutral pH
with a unique mechanism of action. Following subcutaneous injection, insulin
detemir binds to albumin via fatty acid chain, thereby providing slow ... Cited by 2 - Related articles - BL Direct - All 7 versions
- Free from Publisher RK Bernstein - Diabetes care, 2006 - Am Diabetes Assoc Although beyond the scope of the cited review, there is certainly one benign
intervention that is appropriate even before new evidence appears: check blood
glucose before driving and hourly thereafter while driving. A corollary to ... Cited by 1 - Related articles - BL Direct - All 5 versions
I Blumer - Diabetic medicine: a journal of the British Diabetic …, 2008 - ncbi.nlm.nih.gov 1: Diabet Med. 2008 Aug;25(8):1008. Severe, delayed insulin detemir injection
site reaction. Blumer I. Publication Types: Letter. ... Related articles - All 4 versions
B Akinci, S Yener, F Bayraktar, S Yesil - Endocrine - Springer Abstract Although the incidence of insulin allergy decreased after the
introduction of recombinant human insulin preparations, it is still a major
problem which may be life-threatening in some cases. In this article, we ...